Liberty Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Liberty Wealth Management's MRNA Position: Q4 2021 in Review
Liberty Wealth Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 128 shares — an estimated $48K sold.
Liberty Wealth Management first reported a position in MRNA in Q3 2020 and held it in 5 quarters. The position peaked at $48K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.
- Liberty Wealth Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
- Liberty Wealth Management sold 128 Moderna shares in Q4 2021, an estimated $48K.
- Liberty Wealth Management first reported a position in Moderna in Q3 2020 and held it in 5 quarters.
- Liberty Wealth Management's Moderna position peaked at $48K in Q3 2021.
- 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.
Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.